Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R21)

Funding Opportunity Announcement (FOA) Number	PAR-13-326
Companion Funding Opportunity	PAR 13-325, R01 Research Project Grant PAR-13-344, R03 Small Grant Program
Number of Applications	See Section III. 3. Additional Information on Eligibility.
Catalog of Federal Domestic Assistance (CFDA) Number(s)	93.865, 93.173
Funding Opportunity Purpose	This Funding Opportunity Announcement (FOA) encourages grant applications to address different and complementary research needs for the development and acceptability of pediatric drug formulations in different age groups. Development and testing of novel pediatric drug delivery systems is also part of this initiative.

Key Dates

Posted Date	September 4, 2013
Open Date (Earliest Submission Date)	September 16, 2013
Letter of Intent Due Date(s)	30 days prior to the application due date
Application Due Date(s)	Standard dates apply, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)	Standard AIDS dates apply, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.